KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Genomind ®, a leading mental health care company, is launching on August 10, 2019 Genomind Professional PGx Express™, a new, more focused report and set of ...

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Genomind – a leading mental health care company – today announced that its flagship pharmacogenetic product, Genomind Professional PGx™, is now available to ...

KING OF PRUSSIA, PA--(Marketwired - December 10, 2015) - The largest audience to date will soon learn how personalized medicine for brain health is making a difference for patients. "Innovations," an ...

KING OF PRUSSIA, PA--(Marketwired - December 10, 2015) - The largest audience to date will soon learn how personalized medicine for brain health is making a difference for patients. "Innovations," an ...

GLEN ALLEN, Va., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the ...

PHILADELPHIA--(BUSINESS WIRE)-- Audacy announced a multiplatform partnership with mental health innovator Genomind. This breakthrough partnership taps into Audacy’s influencers and Genomind’s ...

KING OF PRUSSIA, PA--(Marketwired - February 08, 2017) - Genomind, a personalized medicine company advancing mental healthcare through genetic testing, has completed an $11 million financing with its ...

King of Prussia-based mental health company Genomind recently expanded its partnership with Acme markets, making its genetic testing service available to patients in all 37 Acme pharmacies across ...

KING OF PRUSSIA, PA--(Marketwired - February 18, 2015) - Genomind, a pharmacogenetic testing laboratory specializing in personalized medicine in the field of psychiatry, today announced the addition ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The company is seeking to raise additional funding ...